Navigation Links
Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis
Date:6/14/2008

o the same period of time prior to treatment. (5-7)

In the presentation by Dr. Hill, data on 164 patients with PNH were derived from two Phase 3 studies of Soliris as a treatment for PNH: TRIUMPH, a six-month, double-blind, placebo-controlled study, and SHEPHERD, a 12-month, open-label study. Data on anemic cancer patients were obtained from a published report.(8) Patient-reported fatigue in both groups of patients was determined utilizing the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue scale. Anemia was measured by levels of hemoglobin, and hemolysis was measured by levels of lactate dehydrogenase (LDH). Key findings included the following:

* While intravascular hemolysis reduction (decreased LDH) and anemia

improvement (increased hemoglobin) were both significantly associated

with fatigue improvement (odds ratio 1.11, P<0.001 and 1.29, P=0.005,

respectively), hemolysis reduction was predictive of an improvement in

fatigue independent of an improvement in anemia in patients with PNH

(1.07, P=0.028).

* The improvement in fatigue was greater (P=0.002) in Soliris-treated PNH

patients compared to EPO-treated anemic cancer patients.

* When the magnitude of clinical impact was analyzed by using standard

descriptors for the Effect Size (ES) measurement of fatigue in both

groups, (9)

* PNH patients treated with Soliris experienced a large improvement in

fatigue, (ES: +1.0) when the hemoglobin level increased as compared to

anemic cancer patients treated with EPO who experienced only a small

improvement in fatigue (ES: +0.48).

* Similarly, PNH patients treated with Soliris experienced a moderate

improvement in fatigue (ES:+0.72) when hemoglobin levels did not

improve compared to EPO-treated anemic cancer patients for whom

fatigue scores did not change meaningfully (ES:+0.15) when hem
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
2. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
3. PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
4. Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
5. Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
6. Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
7. Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder
8. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
9. Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function
10. Data Published at ASCO Find Correlation Between ChemoFx(R) Assay and Significantly Improved Overall Survival in Patients With Ovarian Cancer
11. New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  Isis Pharmaceuticals, Inc. ... Pharmaceuticals, Second Quarter 2014 Financial Results and Highlights Conference ... a.m. PTWhere: www.isispharm.com How:Live on the Internet. Simply ... unable to participate during the live event, a replay ... time at www.isispharm.com . ABOUT ISIS ...
(Date:7/28/2014)... 28, 2014 OmPrompt today ... to help it meet the global demand for ... and logistics. Albion joins Shackleton Ventures. ... Over the past 18 months OmPrompt has underpinned ... management team and its operations. The new funding ...
(Date:7/25/2014)... , July 25, 2014  Depomed, Inc. (NASDAQ: ... second quarter fiscal year 2014 financial results after the ... host a conference call beginning at 4:30 pm EDT, 1:30 ... access the call by dialing 877-317-6789 ( United ... will also be available via a live webcast on ...
Breaking Medicine Technology:Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2OmPrompt Funded for Customer Automation Management Market Expansion 2Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2
... May 7, 2012  Zenobia Therapeutics, Inc. (Zenobia), the ... diseases and FBLD/structural biology services, and BioBlocks, Inc. ... novel building block products, announced today that they ... their product offerings.  The library, ZB-Fragment Library 2, ...
... 7, 2012  BioElectronics Corporation (OTC-PINK: BIEL), the maker ... devices, today announced the completion of a randomized, ... BIEL,s ActiPatch® product.  ActiPatch uses pulsed electromagnetic field ... healing of injured tissue. A ...
Cached Medicine Technology:Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods 2Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods 3BioElectronics' ActiPatch Reduces Muscle Soreness in Runners 2
(Date:7/28/2014)... July 28, 2014 According to court documents, ... owner of The Marcal Group (TMG), met with ... (HMG). A contract, as well a broad project outline, were ... as well as branding services and marketing. , ... by HMG throughout the course of the project, praise was ...
(Date:7/28/2014)... TherapySites, the leading website ... today its affiliation with the Illinois Association for ... allows TherapySites to continue to extend their online marketing ... offers. , “There has been a fundamental shift in ... nearly 3 billion Internet users, it is so important ...
(Date:7/28/2014)... According to the Heartburn No More PDF review recently ... help people get rid of acid reflux naturally. ... heartburn and acid reflux. In addition, inside this book, people ... factors for reflux disease. , Vkool informs in its ... symptoms of reflux disease naturally without medications. The book also ...
(Date:7/28/2014)... 28, 2014 Shore Points Capital announced ... investment in Loftware, Inc., through a recapitalization of the ... was the lead investor in Loftware for over nine ... the leading international provider of enterprise level software solutions ... a great investment for us, and we are proud ...
(Date:7/27/2014)... Petersburg, FL (PRWEB) July 28, 2014 ... water, and that is the key to the power ... our skin," says Kathy Heshelow, founder of Sublime Beauty®. ... topical Hyaluronic serum such as ours improves skin ... in the skin, key to a healthy and beautiful ...
Breaking Medicine News(10 mins):Health News:Calko Medical Center Loses Website Twice over Non-Payment, According to Court Documents 2Health News:TherapySites (Websites for Therapists) Partners with the Illinois Association for Marriage and Family Therapy 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 3Health News:Shore Points Capital Announces Sale of Portfolio Company Loftware 2Health News:Aging or Dry Skin Benefits from Hyaluronic Serum; Now 30% Off Sale at Sublime Beauty® 2
... for some women, study suggests , , , TUESDAY, May ... women, mammography is far from perfect. But, undergoing breast ... cancers in high-risk women, particularly those with dense breast ... authors noted, ultrasound also significantly increases the rate of ...
... slow to a crawl unless regulators work out a host ... opinion piece. , We cant apply a clinical paradigm to ... Nancy Kass, Sc.D., deputy director for public health at the ... the article. , The piece, published in the June issue ...
... May 13 CJPS Enterprises, LLC, (http://www.CJPS-Enterprises.com ) ... mini-seminar and interactive discussions about building up, or,divesting ... and therefore their worth. This seminar will take ... and is applicable to both large,and small companies., ...
... ,Yacht Party, for ... Supporting ,Yacht Tax, Loophole, LOS ANGELES, May 13 The ... the California,Republican Party as the "Yacht Party" for its continued support ... to avoid paying,sales tax in California. The ad, titled "Yacht Party ...
... Attorneys for a married,couple who lived in the fundamentalist ... District Court judge today for an emergency order,to prevent ... is still,nursing, when he turns a year old on ... presiding judge at 3:30 p.m.,seeking an emergency injunction to ...
... DALLAS, May 13 It was a sellout ... using natural botanicals,in its first hour-long show on ... Sandra Bennett and Actifirm president Elysiann Bishop,presented six ... Renovation Eye Cream; Actilash(TM); and a special,four-piece discovery ...
Cached Medicine News:Health News:Coupled With Mammography, Ultrasound Finds More Breast Cancers 2Health News:Coupled With Mammography, Ultrasound Finds More Breast Cancers 3Health News:Treating safety research like other clinical studies slows progress 2Health News:Treating safety research like other clinical studies slows progress 3Health News:Intellectual Property Buildup Seminar to be Held in Detroit 2Health News:California Nurses Association, Courage Campaign, Arianna Huffington Team up for 'Yacht Party 2' TV Ad 2Health News:California Nurses Association, Courage Campaign, Arianna Huffington Team up for 'Yacht Party 2' TV Ad 3Health News:FLDS Couple Seeks Emergency Order to Stop Infant Seizure, Say Perry & Haas 2Health News:FLDS Couple Seeks Emergency Order to Stop Infant Seizure, Say Perry & Haas 3Health News:Actifirm Sells Out in First Hour Appearance on QVC 2
... the challenge of,controlling costs while handling ... data,management is critical. INFINITY modular,patient monitors ... clinical information,wherever you are in the ... your job easier. You can monitor,your ...
... The biograph 6 offers ... improved disease diagnosis and treatment ... It delivers high-quality PET/CT whole ... 15 minutes. Our comprehensive suite ...
... offers the ultimate PET/CT performance ... treatment in oncology, neurology, and ... whole body scans in less ... suite of clinical applications offers ...
... Duo is a SmartBeam platform providing high-performance ... of the two most clinical sites - ... at a low radiation dose., ,The ... Windows, optimizes productivity and ensures consistant results. ...
Medicine Products: